View in EDS HTML Full Text PDF Full Text

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity.

Saved in:
Bibliographic Details
Title: Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity.
Authors: Vanmeerbeek I; Laboratory of Cell Stress & Immunity (CSI), Department of Cellular & Molecular Medicine, KU Leuven, Belgium., Sprooten J; Laboratory of Cell Stress & Immunity (CSI), Department of Cellular & Molecular Medicine, KU Leuven, Belgium., Garg AD; Laboratory of Cell Stress & Immunity (CSI), Department of Cellular & Molecular Medicine, KU Leuven, Belgium.
Source: Molecular oncology [Mol Oncol] 2026 Apr; Vol. 20 (4), pp. 865-868. Date of Electronic Publication: 2026 Jan 21.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1878-0261
DOI:10.1002/1878-0261.70210